BRCA2 and neoplasm: This percentage was significantly higher for the gains of the BRCA1-mutated tumor group but not for the BRCA2-mutated tumor group when compared to the sporadic control tumors (p = 2.5 × 10-3 calculated with t-test with unequal variance) (Figure 4a).